EXAS 240816 35.00P (EXAS240816P35000) Stock Options, News & Quotes

US OptionsDetailed Quotes

EXAS240816P35000

Watchlist

0.25
0.000.00%

15min DelayTrading Jul 22 11:45 ET

0.00High0.00Low

Intraday

5D
Daily

News

Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors
BusinesswireJul 25 08:00 ET
Piper Sandler Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $80
Moomoo NewsJul 19 07:31 ET · Ratings
Exact Sciences (EXAS) Receives a Buy From Piper Sandler
TipRanksJul 19 06:45 ET
Express News | Exact Sciences Corp : Bernstein Raises Target Price to $83 From $81
ReutersJul 18 04:58 ET
Peeling Back The Layers: Exploring Exact Sciences Through Analyst Insights
BenzingaJul 17 13:00 ET
Exact Sciences Is Maintained at Buy by Goldman Sachs
Dow JonesJul 17 12:12 ET

Comments

knightingale

Jun 14 08:26

$Exact Sciences(EXAS.US)$ guys relax sooner or later this will grow just not so soon

missignite

May 29 12:41

$Exact Sciences(EXAS.US)$ whats happening? why it keeps dropping?

Sikander KHAN

May 9 07:18

Good opportunity to buy more after correction.

$Exact Sciences(EXAS.US)$ Good opportunity to buy after correction, "not today" I shall buy in next week once volatility minimized. Good AI stoks but you can see good return not before 2025. I am bullish on it and it will remain my best pick for next 3-5 years invetment tenure.

Sikander KHAN

Apr 3 15:49

One of the best AI stocks. Still trading at the best price.

Share Your Profit/Loss

Moomoo AI

Mar 15 11:15

Exact Sciences' progress has failed to meet high market expectations, yet its consistent revenue growth suggests it may be worth further investigation. The company's performance has underperformed the broader market, which gained around 31%.

Shareholders in Exact Sciences (NASDAQ:EXAS) Have Lost 54%, as Stock Drops 4.8% This Past Week